Imax Analyst Ratings
Imax Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | 60.94% | Rosenblatt | $27 → $30 | Maintains | Buy |
| 08/18/2023 | 60.94% | Rosenblatt | $27 → $30 | Maintains | Buy |
| 07/28/2023 | 28.76% | Barrington Research | → $24 | Reiterates | Outperform → Outperform |
| 07/27/2023 | 39.48% | Wedbush | → $26 | Reiterates | Outperform → Outperform |
| 07/27/2023 | 60.94% | Rosenblatt | $27 → $30 | Maintains | Buy |
| 07/20/2023 | 39.48% | Wedbush | → $26 | Reiterates | Outperform → Outperform |
| 07/13/2023 | 23.39% | Benchmark | → $23 | Reiterates | Buy → Buy |
| 07/13/2023 | 39.48% | Wedbush | → $26 | Reiterates | Outperform → Outperform |
| 07/13/2023 | 44.85% | Rosenblatt | → $27 | Reiterates | Buy → Buy |
| 07/12/2023 | 39.48% | Roth MKM | $26 → $26 | Reiterates | Buy → Buy |
| 05/02/2023 | 28.76% | Barrington Research | → $24 | Reiterates | → Outperform |
| 05/02/2023 | 23.39% | Benchmark | $22 → $23 | Maintains | Buy |
| 04/28/2023 | 44.85% | B. Riley Securities | $26 → $27 | Maintains | Buy |
| 04/28/2023 | 39.48% | Roth MKM | $24 → $26 | Maintains | Buy |
| 04/28/2023 | 34.12% | Wells Fargo | $22 → $25 | Maintains | Overweight |
| 04/28/2023 | 44.85% | Rosenblatt | $25 → $27 | Maintains | Buy |
| 04/25/2023 | 34.12% | Wedbush | $22 → $25 | Maintains | Outperform |
| 04/10/2023 | 39.48% | B. Riley Securities | $23 → $26 | Maintains | Buy |
| 04/05/2023 | 34.12% | Rosenblatt | → $25 | Reiterates | → Buy |
| 02/28/2023 | -24.89% | Goldman Sachs | $12 → $14 | Maintains | Sell |
| 02/23/2023 | 7.3% | Barrington Research | → $20 | Reiterates | → Outperform |
| 02/23/2023 | 1.93% | JP Morgan | $16 → $19 | Maintains | Neutral |
| 02/23/2023 | 34.12% | Rosenblatt | $22 → $25 | Maintains | Buy |
| 01/17/2023 | 18.03% | Rosenblatt | → $22 | Reiterates | → Buy |
| 12/05/2022 | 23.39% | B. Riley Securities | $20 → $23 | Maintains | Buy |
| 11/01/2022 | -14.16% | JP Morgan | $18 → $16 | Maintains | Neutral |
| 11/01/2022 | 12.66% | Wells Fargo | $26 → $21 | Maintains | Overweight |
| 10/10/2022 | -3.43% | JP Morgan | $19 → $18 | Maintains | Neutral |
| 10/06/2022 | 12.66% | Benchmark | $25 → $21 | Maintains | Buy |
| 07/18/2022 | 34.12% | Benchmark | $28 → $25 | Maintains | Buy |
| 06/21/2022 | 34.12% | B. Riley Securities | $30 → $25 | Maintains | Buy |
| 05/24/2022 | 34.12% | Rosenblatt | → $25 | Initiates Coverage On | → Buy |
| 04/29/2022 | 23.39% | MKM Partners | $25 → $23 | Maintains | Buy |
| 10/22/2021 | 44.85% | Wells Fargo | → $27 | Initiates Coverage On | → Overweight |
| 06/02/2021 | -0.21% | Goldman Sachs | $19.6 → $18.6 | Downgrades | Neutral → Sell |
| 04/23/2021 | 39.48% | Wedbush | $22 → $26 | Upgrades | Neutral → Outperform |
| 02/01/2021 | 34.12% | MKM Partners | $18 → $25 | Maintains | Buy |
| 01/25/2021 | -3.97% | Goldman Sachs | $15.6 → $17.9 | Downgrades | Buy → Neutral |
| 07/13/2020 | -3.43% | MKM Partners | $20 → $18 | Maintains | Buy |
| 04/28/2020 | -24.89% | Benchmark | → $14 | Upgrades | Hold → Buy |
| 04/24/2020 | -35.62% | Wedbush | $25 → $12 | Downgrades | Outperform → Neutral |
| 04/15/2020 | 7.3% | MKM Partners | $24 → $20 | Maintains | Buy |
| 03/18/2020 | 1.93% | B. Riley Securities | $26 → $19 | Maintains | Buy |
| 03/17/2020 | — | Benchmark | Downgrades | Buy → Hold | |
| 03/17/2020 | -19.53% | JP Morgan | $22 → $15 | Downgrades | Overweight → Neutral |
| 02/20/2020 | 34.12% | Wedbush | $22 → $25 | Maintains | Outperform |
| 02/13/2020 | 39.48% | B. Riley Securities | $30 → $26 | Reiterates | → Buy |
| 02/03/2020 | 18.03% | Wedbush | $28 → $22 | Maintains | Outperform |
| 01/29/2020 | 7.3% | Benchmark | $28 → $20 | Maintains | Buy |
| 11/01/2019 | — | Canaccord Genuity | Upgrades | Hold → Buy | |
| 02/25/2019 | — | Canaccord Genuity | Downgrades | Buy → Hold | |
| 10/26/2018 | 23.39% | Canaccord Genuity | $26 → $23 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月25日 | 60.94% | 羅森布拉特 | $27→$30 | 維護 | 買 |
| 2023年08月18日 | 60.94% | 羅森布拉特 | $27→$30 | 維護 | 買 |
| 07/28/2023 | 28.76% | 巴靈頓研究公司 | →$24 | 重申 | 跑贏→跑贏大盤 |
| 07/27/2023 | 39.48% | 韋德布什 | →$26 | 重申 | 跑贏→跑贏大盤 |
| 07/27/2023 | 60.94% | 羅森布拉特 | $27→$30 | 維護 | 買 |
| 07/20/2023 | 39.48% | 韋德布什 | →$26 | 重申 | 跑贏→跑贏大盤 |
| 07/13/2023 | 23.39% | 基準 | →$23 | 重申 | 購買→購買 |
| 07/13/2023 | 39.48% | 韋德布什 | →$26 | 重申 | 跑贏→跑贏大盤 |
| 07/13/2023 | 44.85% | 羅森布拉特 | →$27 | 重申 | 購買→購買 |
| 07/12/2023 | 39.48% | 羅斯MKM | $26→$26 | 重申 | 購買→購買 |
| 05/02/2023 | 28.76% | 巴靈頓研究公司 | →$24 | 重申 | →跑贏大盤 |
| 05/02/2023 | 23.39% | 基準 | $22→$23 | 維護 | 買 |
| 04/28/2023 | 44.85% | B.萊利證券 | $26→$27 | 維護 | 買 |
| 04/28/2023 | 39.48% | 羅斯MKM | $24→$26 | 維護 | 買 |
| 04/28/2023 | 34.12% | 富國銀行 | $22→$25 | 維護 | 超重 |
| 04/28/2023 | 44.85% | 羅森布拉特 | $25→$27 | 維護 | 買 |
| 04/25/2023 | 34.12% | 韋德布什 | $22→$25 | 維護 | 跑贏大盤 |
| 04/10/2023 | 39.48% | B.萊利證券 | $23→$26 | 維護 | 買 |
| 04/05/2023 | 34.12% | 羅森布拉特 | →$25 | 重申 | →購買 |
| 02/28/2023 | -24.89% | 高盛 | $12→$14 | 維護 | 賣 |
| 02/23/2023 | 7.3% | 巴靈頓研究公司 | →$20 | 重申 | →跑贏大盤 |
| 02/23/2023 | 1.93% | 摩根大通 | $16→$19 | 維護 | 中性 |
| 02/23/2023 | 34.12% | 羅森布拉特 | $22→$25 | 維護 | 買 |
| 01/17/2023 | 18.03% | 羅森布拉特 | →$22 | 重申 | →購買 |
| 12/05/2022 | 23.39% | B.萊利證券 | $20→$23 | 維護 | 買 |
| 11/01/2022 | -14.16% | 摩根大通 | $18→$16 | 維護 | 中性 |
| 11/01/2022 | 12.66% | 富國銀行 | $26→$21 | 維護 | 超重 |
| 2022年10月10日 | -3.43% | 摩根大通 | $19→$18 | 維護 | 中性 |
| 10/06/2022 | 12.66% | 基準 | $25→$21 | 維護 | 買 |
| 07/18/2022 | 34.12% | 基準 | $28→$25 | 維護 | 買 |
| 2022年06月21日 | 34.12% | B.萊利證券 | $30→$25 | 維護 | 買 |
| 2022年05月24日 | 34.12% | 羅森布拉特 | →$25 | 開始承保 | →購買 |
| 04/29/2022 | 23.39% | MKM合作夥伴 | $25→$23 | 維護 | 買 |
| 10/22/2021 | 44.85% | 富國銀行 | →$27 | 開始承保 | →超重 |
| 06/02/2021 | -0.21% | 高盛 | $19.6→$18.6 | 評級下調 | 中性→銷售 |
| 04/23/2021 | 39.48% | 韋德布什 | $22→$26 | 升級 | 中性→表現優異 |
| 02/01/2021 | 34.12% | MKM合作夥伴 | $18→$25 | 維護 | 買 |
| 2021/01/25 | -3.97% | 高盛 | $15.6→$17.9 | 評級下調 | 購買→中性 |
| 07/13/2020 | -3.43% | MKM合作夥伴 | $20→$18 | 維護 | 買 |
| 04/28/2020 | -24.89% | 基準 | →$14 | 升級 | 持有→購買 |
| 04/24/2020 | -35.62% | 韋德布什 | $25→$12 | 評級下調 | 跑贏→中性 |
| 04/15/2020 | 7.3% | MKM合作夥伴 | $24→$20 | 維護 | 買 |
| 03/18/2020 | 1.93% | B.萊利證券 | $26→$19 | 維護 | 買 |
| 03/17/2020 | - | 基準 | 評級下調 | 購買→Hold | |
| 03/17/2020 | -19.53% | 摩根大通 | $22→$15 | 評級下調 | 超重→中性 |
| 02/20/2020 | 34.12% | 韋德布什 | $22→$25 | 維護 | 跑贏大盤 |
| 02/13/2020 | 39.48% | B.萊利證券 | $30→$26 | 重申 | →購買 |
| 02/03/2020 | 18.03% | 韋德布什 | $28→$22 | 維護 | 跑贏大盤 |
| 1/29/2020 | 7.3% | 基準 | $28→$20 | 維護 | 買 |
| 2019/11/01 | - | 卡納科特·格納奇 | 升級 | 持有→購買 | |
| 2019年02月25日 | - | 卡納科特·格納奇 | 評級下調 | 購買→Hold | |
| 2018年10月26日 | 23.39% | 卡納科特·格納奇 | $26→$23 | 維護 | 買 |
What is the target price for Imax (IMAX)?
Imax(IMAX)的目標價是多少？
The latest price target for Imax (NYSE: IMAX) was reported by Rosenblatt on August 25, 2023. The analyst firm set a price target for $30.00 expecting IMAX to rise to within 12 months (a possible 60.94% upside). 29 analyst firms have reported ratings in the last year.
Rosenblatt於2023年8月25日報道了Imax(紐約證券交易所代碼：IMAX)的最新目標價。這家分析公司將目標價定為30.00美元，預計IMAX將在12個月內上漲(可能上漲60.94%)。去年有29家分析公司公佈了評級。
What is the most recent analyst rating for Imax (IMAX)?
分析師對IMAX的最新評級是多少？
The latest analyst rating for Imax (NYSE: IMAX) was provided by Rosenblatt, and Imax maintained their buy rating.
分析師對Imax(紐約證券交易所代碼：IMAX)的最新評級是由Rosenblatt提供的，Imax維持其買入評級。
When is the next analyst rating going to be posted or updated for Imax (IMAX)?
Imax(IMAX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imax was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Imax的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Imax的上一次評級是在2023年8月25日提交的，所以你應該預計下一次評級將在2024年8月25日左右提供。
Is the Analyst Rating Imax (IMAX) correct?
分析師評級Imax(IMAX)正確嗎？
While ratings are subjective and will change, the latest Imax (IMAX) rating was a maintained with a price target of $27.00 to $30.00. The current price Imax (IMAX) is trading at is $18.64, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Imax(IMAX)評級維持不變，目標價在27.00美元至30.00美元之間。Imax(IMAX)目前的交易價格為18.64美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。